EUVIMED · CrossrefZeitschrift
Med
ISSN 2666-6340 · Elsevier BV
Neueste Artikel
Geographic disparities and aging-related burden in reperfusion service output for acute ischemic stroke in China: A national sample spatial analysis
Imaging-detected extranodal extension grading and T-category adjustment to refine the TNM-9 classification for nasopharyngeal carcinoma
Interpretation of genome sequencing results in children with complex neuromotor phenotypes
Metabolic endotyping for mechanism-informed Alzheimer’s and Parkinson’s disease trials
Tissue-reactive zonation of mesenchymal-like phenotypes in human glioblastoma
Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities
First human decedent model of orthotopic multi-organ xenotransplantation: Whole liver and bilateral kidneys from a six-gene-edited pig
Current state of CAR-T cell therapies for solid tumors
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome
Rethinking the role of synergy calculations in the next century of drug combination discovery
COPD reshapes the tumor microenvironment of NSCLC and enhances anti-PD-1 therapy response
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
Anti-CD19 CAR T cell therapy for refractory SLE-ITP
μPharma: A microfluidic, AI-driven pharmacotyping platform for single-cell drug sensitivity prediction in leukemia
Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cells
Hepatocellular carcinoma: Clinical trials to watch
Challenges and opportunities in the network medicine of complex diseases
The comings and goings of cell-free DNA: Biological and clinical implications
Sprayed low-temperature plasma-infused hydrogel dressing for skin-wound management
Thirty years of intravenous thrombolysis for acute ischemic stroke: Historical perspectives, evidence from randomized trials, and emerging directions
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial
Application of generative artificial intelligence to utilize unstructured clinical data for acceleration of inflammatory bowel disease research
Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial
Progressive multiple sclerosis: Six trials to watch
Cell-free DNA in 2030
Gut microbiota predictive of the efficacy of consolidation immunotherapy and chemoradiotherapy toxicity in lung cancer
Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment
Safety and tolerability of intrarectal perfluorodecalin for enteral ventilation in a first-in-human trial
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)
Trends and sociodemographic patterns in hypertension prevalence and treatment in China
EUVIMED